Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research on Evaluating Rifapentine-Based Shorter Regimens for Tuberculosis and Tuberculosis Infection Among People Living With and Without HIV in Programmatic Settings in Kazakhstan (RIFA-REAL)

NCT07668479 is registered in ClinicalTrials.gov with Public Union "Kazakhstan Association of Phthisiopulmonologists" as lead sponsor.

NCT NCT07668479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07668479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research on Evaluating Rifapentine-Based Shorter Regimens for Tuberculosis and Tuberculosis Infection Among People Living With and Without HIV in Programmatic Settings in Kazakhstan (RIFA-REAL)
Lead sponsor
Public Union "Kazakhstan Association of Phthisiopulmonologists"
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
August 31, 2027
Enrollment
350 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis, tuberculosis infection, latent, tuberculosis, pulmonary, drug sensitive